Li-Cycle Holdings Corp. (LICY) announces a collaboration with Arrival (ARVL), a global company that is on a mission to make air clean by replacing all vehicles with affordable electric solutions produced by local microfactories.
G1 Therapeutics (GTHX) announces that the Company has initiated a Phase 2, single arm, open-label study of trilaciclib administered prior to the antibody-drug conjugate, Trodelvy in patients with unresectable locally advanced or metastatic triple-negative breast cancer. Antitumor efficacy and myeloprotective endpoints are being assessed in this trial. Initial results of this study are expected in the second half of 2022.
Shutterstock (SSTK) announces a collaboration with distinguished global visual artist, Bradley Theodore, for an exclusive and immersive Art Basel Miami Beach fringe event.
Verrica Pharmaceuticals (VRCA) has resubmitted the New Drug Application for VP-102 for the treatment of molluscum contagiosum to the U.S. Food and Drug Administration.
